Jazz Pharmaceuticals PLC (JAZZ)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	414,832	79,954	-86,514	-156,287	-224,060	-18,687	-51,872	-449,853	-329,668	-160,903	40,164	518,281	238,616	179,194	133,236	280,333	523,367	608,845	655,885	486,308
Revenue (ttm)	US$ in thousands	3,809,836	3,720,411	3,685,651	3,662,251	3,569,427	3,471,828	3,371,195	3,194,350	2,999,693	2,864,101	2,628,980	2,436,329	2,361,556	2,277,779	2,214,357	2,184,676	2,158,500	2,053,217	1,985,763	1,953,884
Net profit margin		10.89%	2.15%	-2.35%	-4.27%	-6.28%	-0.54%	-1.54%	-14.08%	-10.99%	-5.62%	1.53%	21.27%	10.10%	7.87%	6.02%	12.83%	24.25%	29.65%	33.03%	24.89%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $414,832K ÷ $3,809,836K
= 10.89%

The net profit margin of Jazz Pharmaceuticals plc has shown variations over the past eight quarters. In Q4 2023, the net profit margin stood at 10.82%, indicating the company generated a net profit of 10.82% for every dollar of revenue earned during the period. This represents a significant improvement compared to the previous quarter, Q3 2023, where the net profit margin was only 2.11%.

In Q2 2023 and Q1 2023, the company experienced negative net profit margins of -2.30% and -4.18% respectively, indicating that expenses exceeded revenues during these periods. This downward trend in profitability was consistent with the negative net profit margins recorded in Q4 2022 (-6.12%), Q3 2022 (-0.52%), Q2 2022 (-1.49%), and Q1 2022 (-13.63%).

Overall, the varying net profit margins suggest fluctuations in the company's financial performance and profitability over the evaluated periods. Significant efforts may be required to sustain and improve profitability in the future quarters for Jazz Pharmaceuticals plc.